Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB06643"

PredicateValue (sorted: default)
rdfs:label
"Denosumab"
rdf:type
drugbank:drugs
drugbank:description
"Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption markers in patients with a variety of metastatic tumors and is being investigated in multiple clinical trials for the prevention and treatment of bone metastases. Chemically, it consists of 2 heavy and 2 light chains. Each light chain consists of 215 amino acids. Each heavy chain consists of 448 amino acids with 4 intramolecular disulfides. FDA approved on June 1, 2010. "
drugbank:drugCategory
drugcategory:Bone Density Conservation Agents
drugcategory:Monoclonal antibodies
drugbank:interactsWith
drug:Rilonacept
drug:Pralatrexate
drug:Belimumab
drug:Tofacitinib
owl:sameAs
drug:Rilonacept
drug:Pralatrexate
drug:Belimumab
drug:Tofacitinib

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt

The resource appears as object in 8 triples

Context graph